Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Hepatitis C virus drug-drug interactions: a comparison of online drug interaction databases.
Journal: The International journal of pharmacy practice
Published: April 09, 2025
Didactic Education on Viral Hepatitis Elimination within Medical School Curricula in the United States.
Journal: Digestive diseases and sciences
Published: March 27, 2025
Health Care Resource Utilization and Costs Associated with US Medicaid Sobriety Restrictions on Direct-Acting Antivirals for Hepatitis C Virus: A Retrospective Claims Database Analysis.
Journal: PharmacoEconomics
Published: March 18, 2025
A National Survey of Pharmacist Involvement in Hepatitis C Virus Management in the United States.
Journal: Journal of viral hepatitis
Published: May 22, 2024
Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program.
Journal: BMC health services research
Published: November 24, 2023
A cross-sectional survey of viral hepatitis education within pharmacy curricula in the United States.
Journal: International journal of clinical pharmacy
Published: July 19, 2023
Pellet-based hepatitis C virus treatment with glecaprevir/pibrentasvir: A case report of an adult with short bowel syndrome.
Journal: Journal of hepatology
Published: June 15, 2023
Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment.
Journal: World journal of hepatology
Published: December 09, 2022
Sustained Virologic Response Rates Before and After Removal of Sobriety Restriction for Hepatitis C Virus Treatment Access.
Journal: Public health reports (Washington, D.C. : 1974)
Published: June 08, 2022
High Real-World Sustained Virologic Response Rate with Glecaprevir/Pibrentasvir at a Racially Diverse Urban Academic Medical Center.
Journal: Gut and liver
Published: October 27, 2021
Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C virus retreatment in decompensated cirrhosis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 31, 2021
Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings.
Journal: Journal of hepatology
Published: February 01, 2021
Last Updated: 09/26/2026